Fat accumulation and obesity-related cardiovascular risk factors in middle-aged Japanese men and women

Internal Medicine

Volumn 53, Issue 4, 2014, Pages 299-305

  Ryo, Miwa ^a   Funahashi, Tohru ^a   Nakamura, Tadashi ^a   Kihara, Shinji ^a   Kotani, Kazuaki ^b   Tokunaga, Katsuto ^c   Matsuzawa, Yuji ^d   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Sekiyama Clinic   (Japan)

^c Itami City Hospital   (Japan)

^d SUMITOMO HOSPITAL   (Japan)

Author keywords

Dyslipidemia; Glucose tolerance; Metabolic syndrome; Visceral fat

Indexed keywords

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY FAT DISTRIBUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INTRA-ABDOMINAL FAT; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS; SUBCUTANEOUS FAT;

EID: 84893934536     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.9476     Document Type: Article

References (27)

1. Tokunaga K, Matsuzawa Y, Ishikawa K, et al. A novel technique for the determination of body fat by computed tomography. Int J Obes 7: 437-445, 1983.
2. Fujioka S, Matsuzawa Y, Tokunaga K, et al. Contribution of intraabdominal fat accumulation to the impairmalest of glucose and lipid metabolism in human obesity. Metabolism 36: 54-59, 1987.
3. Kanai H, Matsuzawa Y, Kotani K, et al. Close correlation of intraabdominal fat accumulation to hypertension in obese females. Hypertension 16: 484-490, 1990.
4. Nakajima T, Fujioka S, Tokunaga K, et al. Correlation of intraabdominal fat accumulation and left ventricular performance in obesity. Am J Cardiol 64: 369-373, 1989.
5. Nakamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the developmalest of coronary artery disease in non-obese males. Atherosclerosis 107: 239-246, 1994.
6. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complication of obesity. J Clin Endocrinol Metab 54: 254-260, 1982.
7. Bjorntorp P. Obesity and the risk of cardiovascular disease. Ann Intern Med 17: 3-9, 1985.
8. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149: 1514-1520, 1989.
9. Matsuzawa Y, Fujioka S, Tokunaga K, et al. Classification of obesity with respect to morbidity. Proceedings of the Society for Experimental Biology and Medicine (PSEBM) 200: 197-201, 1992.
10. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
11. Hotamisligil GS, Arner P, Caro JF, Atkinson RL. Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95: 2409-2415, 1995.
12. Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nature Med 2: 800-803, 1996.
13. Fujioka S, Matsuzawa Y, Tokunaga K, et al. Improvemalest of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premalesopausal females with visceral fat obesity. Int J Obes 15: 853-859, 1991.
14. Kanai H, Tokunaga K, Fujioka S, et al. Decrease in intraabdominal visceral fat may reduce blood pressure in obese hypertensive females. Hypertension 27: 125-129, 1996.
15. Okauchi Y, Nishizawa H, Funahashi T, et al. Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care 30: 2392-2394, 2007.
16. Hiuge-Shimizu A, Kishida K, Funahashi T, et al. Reduction of visceral fat correlates with the decrease in the number of obesityrelated cardiovascular risk factors in Japanese with Abdominal Obesity (VACATION-J Study). J Atheroscler Thromb 19: 1006- 1018, 2012.
17. Okauchi Y, Kishida K, Funahashi T, et al. Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population. Diabetes Care 32: e122, 2009.
18. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology 211: 283-286, 1999.
19. Matsuzawa Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb 12: 301, 2005.
20. Nakamura T, Tsubono Y, Kameda-Takemura K, et al; Group of the Research for the Association between Host Origin and Atherosclerotic Diseases under the Preventive Measure for Work-related Diseases of the Japanese Labor Ministry. Magnitude of sustained multiple risk factors for ischemic heart disease in Japanese employees: a case-control study. Jpn Circ J 65: 11-17, 2001.
21. Matsuzawa Y, Funahashi T, Kihara S, et al. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24: 29-33, 2004.
22. Funahashi T, Matsuzawa Y. Metabolic syndrome: clinical concept and molecular basis. Ann Med 39: 482-494, 2007.
23. Hiuge-Shimizu A, Kishida K, Funahashi T, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med 44: 82-92, 2012.
24. Balkau B, Deanfield JE, Despres JP, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116: 1942-1951, 2007.
25. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161: 397-405, 2001.
26. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22: 920-924, 1999.
27. Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 18: 207-212, 1994.